Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival (Q59391308)
Jump to navigation
Jump to search
scientific article published on 26 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival |
scientific article published on 26 March 2014 |
Statements
Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival (English)
Lorelei Mucci
Christopher J Sweeney
Kathryn P Gray
Lauren C Harshman
Carolyn Evan
Raina Fichorova
Jaya Sharma